Atlas Trials

A Single-arm Phase II Study of Post-Transoral Robotic Surgery (TORS) Alone to the Primary Tumor Site and Selective Neck Dissection (SND) Followed by Adjuvant Radiation Therapy (+/- Chemotherapy) to the Regional Nodes for Advanced Stage, Human Papilloma Virus (HPV) Positive, Oropharyngeal Cancer

Clinical trial NCT02159703 · COMPLETED

Trial details

NCT number
NCT02159703
Sponsor
Abramson Cancer Center at Penn Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Oropharyngeal Cancer
Start date
2014-02-01
Primary completion
2018-02-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.